Hyperbilirubinaemia is a ubiquitous transitional morbidity in the vast majority of newborns
and a leading cause of hospitalisation in the first week of life worldwide. While timely and …

Acute bilirubin encephalopathy (ABE) is still an insufficiently addressed cause of mortality
and long-term morbidity in low-and middle-income countries (LMICs). This article highlights …

BACKGROUND: To prevent severe hyperbilirubinemia and bilirubin neurotoxicity, the
American Academy of Pediatrics' management guideline for hyperbilirubinemia in near term …

Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant
35 or More Weeks of Gestation | Pediatrics | American Academy of Pediatrics Skip to Main …

Hyperbilirubinaemia is one of the most frequent problems in otherwise healthy newborn
infants. Early discharge of the healthy newborn infants, particularly those in whom …

Most preterm infants less than 35 weeks gestational age (GA) have elevated total
serum/plasma bilirubin (TB) levels, which often present as jaundice, the yellowish …

Hyperbilirubinaemia, presenting as jaundice, is a ubiquitous and frequently benign
condition in newborn babies but is a leading cause of hospitalisation in the first week of life …

Hyperbilirubinemia and kernicterus are re-emerging as prominent clinical concerns and
have been hypothesized to be secondary to increased breast-feeding rates, early hospital …

Background Early detection and treatment of neonatal hyperbilirubinemia is important in the
prevention of bilirubin-induced encephalopathy. In this study, we evaluated the New Jersey …

Background: Severe neonatal hyperbilirubinemia, when unmonitored or untreated, can
progress to acute bilirubin encephalopathy (ABE). Initiatives to prevent and eliminate post …